2017
Reference values of cardio-ankle vascular index in a random sample of a white population
WOHLFAHRT, P., R. CIFKOVA, N. MOVSISYAN, Šárka KUNZOVÁ, Jiří LEŠOVSKÝ et. al.Základní údaje
Originální název
Reference values of cardio-ankle vascular index in a random sample of a white population
Autoři
WOHLFAHRT, P. (203 Česká republika), R. CIFKOVA (203 Česká republika), N. MOVSISYAN (203 Česká republika), Šárka KUNZOVÁ (203 Česká republika), Jiří LEŠOVSKÝ (203 Česká republika), M. HOMOLKA (203 Česká republika), Vladimír SOŠKA (203 Česká republika, domácí), Petr DOBŠÁK (203 Česká republika, domácí), F. LOPEZ-JIMENEZ (840 Spojené státy) a Ondřej SOCHOR (203 Česká republika, garant)
Vydání
journal of Hypertension, PHILADELPHIA, William and Wilkins, 2017, 0263-6352
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 4.099
Kód RIV
RIV/00216224:14110/17:00098395
Organizační jednotka
Lékařská fakulta
UT WoS
000411899000018
Klíčová slova anglicky
arterial stiffness; cardio-ankle vascular index; reference values; white population
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 20. 3. 2018 18:43, Soňa Böhmová
Anotace
V originále
Objectives: Cardio-ankle vascular index (CAVI), a parameter of arterial stiffness, has been increasingly used for cardiovascular risk estimation. Currently used CAVI reference values are derived from the Japanese population. It is not clear whether the same reference values can be used in the white population. The aim of the present study was to describe cardiovascular risk factors influencing CAVI and to establish CAVI reference values. Methods: A total of 2160 individuals randomly selected from the Brno city population aged 25-65 years were examined. Of these, 1347 patients were free from cardiovascular disease, nondiabetic and untreated by antihypertensive or lipid-lowering drugs, forming the reference value population. CAVI was measured using the VaSera VS-1000 device (Fukuda Denshi, Tokyo, Japan). Results: At each blood pressure (BP) level, there was a quadratic association between CAVI and age, except for a linear association in the optimal BP group. Although there was no association between BP and CAVI in younger patients, there was a linear association between CAVI and BP after 40 years of age. Reference values by age and sex were established. In each age group, except for the male 60-65-year group, reference values in our population were lower than in the Japanese one with the difference ranging from -0.29 to 0.21 for men, and from -0.38 to -0.03 for women. Conclusion: This is the first study providing CAVI reference values in a random sample of the white population. Our results suggest that the currently used values slightly overestimate CAVI in younger white, possibly underestimating cardiovascular risk.